Abstract

Eosinophilic inflammation represents a hallmark for allergic asthma. Eosinophils differentiate in the bone marrow from CD34+ cells and are released into the blood and traffic to the lung tissue. To date, the majority of studies originate from animal models or from humans after allergen exposure. Thus, it is unclear if mature eosinophils and eosinophil progenitors express similar levels of trafficking related molecules. Therefore, we characterized the expression of trafficking related molecules on circulating eosinophil progenitors in patients with stable asthma. Participants, 13 patients with stable asthma; 7 at the high end (≥0.3x109/l) and 6 at the low end (≤0.2x109/l) of normal range of blood eosinophils, and 5 healthy controls were selected from the West Sweden Asthma Study. Airway eosinophils were studied in induced sputum. Mature (CD45+IL-5Rα+SSChigh) and progenitors (CD45+CD34+IL-5Rα+SSClow) eosinophils and their expression of selectin (PSGL-1), integrins (VLA-4:CD49d+CD29+, Mac-1:CD11b+CD18+), eotaxin(s) receptor (CCR3+), activation (CD69+, CD25+) and apoptosis (active-caspase 3, CD95+) were quantified in fresh blood by flow cytometry. Asthma patients with high blood eosinophils had increased sputum eosinophils and blood eosinophil progenitors compared to the healthy controls (p<0.05). Mature eosinophils and eosinophil progenitors expressed similar levels of PSGL-1 and VLA-4. Mac-1 was expressed in all mature eosinophils but was reduced in progenitors, in all groups (<0.01). Mature eosinophils expressed higher levels of CCR3 compared to progenitors (p<0.05). However, the CCR3+ eosinophil progenitors showed increased expression of CD25 and CD69 i.e. were more activated in all groups (<0.01) compared to mature eosinophils. No differences in the expression of apoptosis related markers were found between CCR3+ eosinophil progenitors and CCR3+ mature eosinophils. Circulating eosinophil progenitors in patients with stable asthma express major trafficking related receptors found in mature eosinophils, thus suggest their capacity for migrating to the lung tissue. Notably, the eosinophil progenitors primed to eotaxin(s) (CCR3+) are highly activated compared to mature eosinophils.

Highlights

  • Eosinophilic inflammation represents a hallmark for allergic asthma

  • The majority of studies originate from animal models or from humans after allergen exposure. It is unclear if mature eosinophils and eosinophil progenitors express similar levels of trafficking related molecules

  • We characterized the expression of trafficking related molecules on circulating eosinophil progenitors in patients with stable asthma

Read more

Summary

Introduction

Eosinophilic inflammation represents a hallmark for allergic asthma. Eosinophils differentiate in the bone marrow from CD34+ cells and are released into the blood and traffic to the lung tissue. Circulating eosinophil progenitors express major trafficking related molecules and are more activated compared to mature eosinophils in patients with asthma From EAACI International Severe Asthma Forum (ISAF 2012) Gothenburg, Sweden. Background Eosinophilic inflammation represents a hallmark for allergic asthma.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.